Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.

Reardon G, Pandya N, Nutescu EA, Lamori J, Damaraju CV, Schein J, Bookhart BK.

Am J Geriatr Pharmacother. 2012 Dec;10(6):361-72. doi: 10.1016/j.amjopharm.2012.11.003.

PMID:
23217529
2.

Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation.

Patel AA, Reardon G, Nelson WW, Philpot T, Neidecker MV.

Clin Ther. 2013 Nov;35(11):1794-804. doi: 10.1016/j.clinthera.2013.09.010. Epub 2013 Oct 15.

PMID:
24139051
3.

One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.

Chen SY, Wu N, Gulseth M, LaMori J, Bookhart BK, Boulanger L, Fields L, Schein J.

J Manag Care Pharm. 2013 May;19(4):291-301.

4.

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.

Clin Ther. 2004 Jul;26(7):1149-59.

PMID:
15336480
5.

Incidence of venous thromboembolism in nursing home residents.

Reardon G, Pandya N, Nutescu EA, Lamori J, Damaraju CV, Schein J, Bookhart B.

J Am Med Dir Assoc. 2013 Aug;14(8):578-84. doi: 10.1016/j.jamda.2013.02.003. Epub 2013 Mar 13.

6.
7.

Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.

Rahme E, Feugère G, Sirois C, Weicker S, Ramos E.

Thromb Res. 2013 Mar;131(3):210-7. doi: 10.1016/j.thromres.2012.12.004. Epub 2013 Jan 3.

PMID:
23290095
8.

Warfarin use in nursing home residents: results from the 2004 national nursing home survey.

Ghaswalla PK, Harpe SE, Slattum PW.

Am J Geriatr Pharmacother. 2012 Feb;10(1):25-36.e2. doi: 10.1016/j.amjopharm.2011.12.001. Epub 2012 Jan 9.

PMID:
22226690
9.

Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.

Xie L, Liu X, Phatak H, Mardekian J, Tan W, Baser O, Ramacciotti E.

Am J Ther. 2016 Nov/Dec;23(6):e1744-e1753.

PMID:
26214203
10.

Treatment patterns and outcomes among hospitalized patients with venous thromboembolism in the United States: an analysis of electronic health records data.

Menzin J, Preblick R, Friedman M, Menzin J, Frean M, Jacqueline Kwong W.

Hosp Pract (1995). 2014 Oct;42(4):59-74. doi: 10.3810/hp.2014.10.1143.

PMID:
25502130
11.

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.

Agarwal S, Bennett D, Smith DJ.

Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.

PMID:
20104933
12.
13.

Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.

Caprini JA, Tapson VF, Hyers TM, Waldo AL, Wittkowsky AK, Friedman R, Colgan KJ, Shillington AC; NABOR Steering Committee.

J Vasc Surg. 2005 Oct;42(4):726-33.

14.

Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.

Galanaud JP, Bosson JL, Genty C, Presles E, Cucherat M, Sevestre MA, Quere I, Decousus H, Leizorovicz A.

J Thromb Haemost. 2012 Jun;10(6):1004-11. doi: 10.1111/j.1538-7836.2012.04704.x.

15.

Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.

Jones KL, Barnett C, Gauthier M, Boster B, Espirito JL, Michaud LB.

J Oncol Pharm Pract. 2012 Mar;18(1):122-7. doi: 10.1177/1078155210397775. Epub 2011 Mar 1.

PMID:
21364079
16.

Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.

Nordstrom BL, Evans MA, Murphy BR, Nutescu EA, Schein JR, Bookhart BK.

Curr Med Res Opin. 2015 Mar;31(3):439-47. doi: 10.1185/03007995.2014.998814. Epub 2014 Dec 30.

PMID:
25495136
17.

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.

Kahn SR, Springmann V, Schulman S, Martineau J, Stewart JA, Komari N, McLeod A, Strulovitch C, Blostein M, Faucher JP, Gamble G, Gordon W, Kagoma PK, Miron MJ, Laverdière D, Game M, Mills A.

Thromb Haemost. 2012 Sep;108(3):493-8. doi: 10.1160/TH12-03-0169. Epub 2012 Jul 10.

PMID:
22782073
18.

Dementia and risk of adverse warfarin-related events in the nursing home setting.

Tjia J, Field TS, Mazor KM, Donovan JL, Kanaan AO, Reed G, Doherty P, Harrold LR, Gurwitz JH.

Am J Geriatr Pharmacother. 2012 Oct;10(5):323-30. doi: 10.1016/j.amjopharm.2012.09.003.

PMID:
23063288
19.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
20.

Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.

Kaatz S, Fu AC, AbuDagga A, LaMori J, Bookhart BK, Damaraju CV, Tan H, Schein J, Nutescu E.

Thromb Res. 2014 Oct;134(4):807-13. doi: 10.1016/j.thromres.2014.07.027. Epub 2014 Jul 23.

PMID:
25127013

Supplemental Content

Support Center